Advertisement

Related Videos

Opening Session Panel Discussion

Boon-Cher Goh, MD, on Cancer Drugs in Singapore: 3As (Availability, Accessibility, and Affordability)

Welcome and Introduction to Vi3C

Robin Feldman, JD: Are Dubious Patents a Large or Small Issue?

CS Pramesh, MS, FRCS, on Opportunities in India: A Perspective From a Low-Middle Income Country

Advertisement

Advertisement




Jan
12
Today In Oncology
In Head-to-Head Comparison, Fixed-Duration Treatment Noninferior to Continuous for Previously Untreated CLL
Can KDM6A Mutations Help Guide Treatment Selection in Bladder Cancer
Anaplastic Glioma Concurrent vs Adjuvant Temozolomide
Molecular Profile–Based Adjuvant Treatment in High-Intermediate Risk Endometrial Cancer
Refractory LBCL CD19-Targeting CAR T-Cell Therapy Plus Rituximab
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo